Q1 EPS Estimate for Werewolf Therapeutics Lowered by Analyst
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Free Report) – Equities researchers at HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for Werewolf Therapeutics in a research report issued on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings per share of ($0.43) for the quarter, down […]
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Free Report) – Equities researchers at HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for Werewolf Therapeutics in a research report issued on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings per share of ($0.43) for the quarter, down […]
